share_log

Candel Therapeutics | 8-K: Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

SEC ·  Nov 14 21:21
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.